Investor Announcements - 2015
|
| ||
Studies confirm utility of PointMan for molecular analysis of CTCs and circulating DNA in liquid biopsies | ||
| ||
EKF Diagnostics announces the UK launch of the Altair™ 240 clinical chemistry analyser at the Institute of Biomedical Science Congress 2015 in Birmingham, UK, 28-30 September. | ||
| ||
EKF announces that two research posters supporting its PointMan™ molecular diagnostic technology have been delivered at key conferences. | ||
| ||
Two research posters supporting PointMan™ molecular diagnostic technology have been delivered at key conferences. | ||
| ||
Extension to deadline under Rule 2.6(c) of the City Code on Takeovers and Mergers. | ||
| ||
EKF announces that it has recently won two new tenders for its Hemo Control point-of-care hemoglobin analyser. | ||
| ||
EKF announces that it has recently won two new tenders for its Hemo Control point-of-care hemoglobin analyser. | ||
| ||
Public Opening Position Disclosure by a Party to an Offer. Rules 8.1 and 8.2 of the Takeover Code. | ||
| ||
Non-binding proposal for Point of Care division withdrawn. | ||
| ||
| |||||||||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.